X2V73Q7
Restriction Coronary Sinus to New Technology Group 7 with Reduction Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | V Restriction |
| Body Part | 7 Coronary Sinus |
| Approach | 3 Percutaneous |
| Device | Q Reduction Device |
| Qualifier | 7 New Technology Group 7 |
Operation Definition
Partially closing an orifice or the lumen of a tubular body part
Procedure Overview
This family covers procedures that narrow rather than close off a blood vessel or chamber, most notably placement of a coronary sinus reducer for patients with disabling angina that has not responded to medication, bypass surgery, or stenting, and whose coronary arteries are not amenable to further revascularization. The device is an hourglass-shaped implant delivered by catheter into the coronary sinus, the vein that drains blood from the heart muscle back to the right atrium. By creating a controlled narrowing at that point, it raises pressure in the small veins upstream, which appears to redistribute blood flow toward oxygen-starved areas of heart muscle and reduce chest pain episodes.
Patients considered for this therapy typically have exhausted standard options and continue to have frequent angina that limits daily activity. The procedure is done in a catheterization lab under fluoroscopic guidance, generally as an outpatient or short-stay procedure, and does not involve opening the chest.
Anatomy & Axis Detail
Coronary Sinus
The coronary sinus is the short venous channel on the posterior heart surface that collects deoxygenated blood from the cardiac veins before it drains into the right atrium, and it also serves as the anatomic landmark for delivering left ventricular pacing leads in cardiac resynchronization therapy. Restricting this structure with new-technology devices is typically performed to narrow its diameter, a technique used in coronary sinus reduction procedures intended to redistribute coronary blood flow and relieve refractory angina in patients who are not candidates for revascularization. The sinus's proximity to the atrioventricular groove and its variable size make precise device sizing important, since over-restriction risks impairing venous drainage from the heart. Documentation should confirm the device type and the degree of narrowing achieved, distinguishing this from restriction of the coronary arteries themselves.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Reduction Device
This value denotes a device used to physically reduce the size, volume, or dimension of an anatomic structure as part of a therapeutic procedure, distinguishing it from devices that instead replace, bypass, or support a structure. Its exact clinical application depends on the body system and procedure it is coded alongside. The reduction effect is the device's defining functional characteristic within this New Technology group.
Qualifier: New Technology Group 7
As a qualifier value, Group 7 marks a code as belonging to the set of new technologies approved for use in the 2020-2021 fiscal year, a period that included a notable expansion of infectious-disease-related add-on codes. The label does not describe what the technology does; that detail sits in the table and other axis values. It is distinguished from adjoining groups solely by its approval-year cohort.
Coding & Documentation
Assignment depends on documentation identifying the coronary sinus as the treated body part and confirming that a new-technology intraluminal device was deployed, since this root operation and device combination is what distinguishes the procedure from a standard coronary intervention. The operative note should specify catheter-based delivery and device sizing/deployment, along with confirmation of correct final position by contrast venography. A common assignment error is defaulting to a generic Dilation or Occlusion code for coronary sinus work, when the reducer's mechanism is a partial, fixed narrowing rather than either widening a vessel or completely blocking it. Coders should also verify the approach value reflects percutaneous access and confirm the device is captured under the correct new-technology group rather than a conventional device value.